Introduction
Apoptosis is an autonomous cell suicide pathway which is characterised by speci®c morphological changes. The cellular machinery necessary for the execution of the death programme is present in most cell types in an inactivated form (Ra et al., 1993) . This state of inhibition is dependent on survival signals delivered by exogenous signals such as growth factors or adhesion molecules (Boudreau et al., 1995; Harrington et al., 1994) . The death programme can be switched on by active process, for example the engagement of the surface molecules Fas, cell mediated cytotoxicity or radiation-induced DNA damage (Henkart, 1994; Lowe et al., 1993; Nagata and Goldstein, 1995) . Two major gene families are involved in the regulation of apoptosis: the ICE-like family of proteases (reviewed in Martin and Green, 1995) and the Bcl-2 family. Over-expression of Bcl-2 or Bcl-XL, members of this family, can inhibit apoptosis induced by removal of survival signals or by the delivery of a death signal (Oltvai and Korsmeyer, 1994) . Although Bcl-2 has been implicated in the regulation of Ca 2+¯u x inside the cell (Bay et al., 1993; Lam et al., 1994) and in the metabolism of free radicals (Hockenbery et al., 1993; Jacobson and Ra, 1995) the exact mechanism of action of these proteins is still unknown. Regulation of Bcl-2 expression or function by growth factor mediated survival signals is also controversial. In some systems, survival factors up-regulate the transcription of Bcl-2 (Deng and Podack, 1993; Miyazaki et al., 1995; Otani et al., 1993) . However, cells can die without down-regulation of Bcl-2 expression and growth factors can inhibit apoptosis in the absence of RNA or protein synthesis (Canman et al., 1995; Cleveland et al., 1994; Harrington et al., 1994; Jacobson et al., 1994) . Phosphorylation of Bcl-2 has also been reported but this has been correlated both with increased protection against death (May et al., 1994) and increased sensitivity to death (Haldar et al., 1995) . Some of this complexity is probably explained by homo and heterodimerisation of Bcl-2, Bcl-X and other members of the Bcl-2 family having death promoting activities (Oltvai and Korsmeyer, 1994) .
The role played by Bcl-2 and Bcl-X expression in the growth factor induced survival of hematopoietic cells, has been studied in the bone marrow derived cell line Baf-3. These cells are dependent on IL-3 for their growth and survival in culture. IL-3 binds to a receptor which is a member of the hematopoietin family and is composed of an a chain speci®c for IL-3 and a b chain. The bc chain is responsible for signal transduction and is common to the IL-3, interleukin-5 and GM-CSF receptors. The cytoplasmic region of the bc chain has been extensively studied and can be subdivided into dierent domains (Kinoshita et al., 1995a) . The membrane-proximal domain is responsible for activation of Jak2 and expression of c-Myc and is essential for proliferation. The membrane-distal domain is essential for survival and is responsible for activationinduced tyrosine phosphorylation, activation of Ras, Raf and MAP-kinases as well as induction of the early response genes c-Fos and c-Jun (Kinoshita et al., 1995b) . In Baf-3 cells survival can be mediated via the Ras pathway, as activated Ras can complement a truncated GM-CSF receptor bc chain which has lost the ability to transduce a survival signal (Kinoshita et al., 1995a) .
IL-4 and IGF-1, which activate dierent signalling pathways (Lienhard, 1994; Welham et al., 1992 ) also allow Baf-3 cells to survive, but the cells cycle more slowly than in the presence of IL-3 (RodriguezTarduchy et al., 1992a,b) .
In this study, we show that, upon IL-3 removal, down-regulation of Bcl-X but not Bcl-2 gene expression precedes the onset of apoptosis. The rapid inhibition of apoptosis induced by re-addition of IL-3 and IGF-1 is not dependent on induction of Bcl-X gene expression since IL-3 and IGF-1 can delay the apoptosis of Baf-3 cells in the presence of RNA or protein synthesis inhibitors. Long-term survival (more than 24 h) of Baf-3 cells can be achieved only with IL-3 or IGF-1, and this correlates with strong upregulation of Bcl-X gene expression by a MAP-kinase dependent pathway.
Results
In Baf-3 cells IL-3 tightly regulates the expression of the Bcl-X but not Bcl-2 gene To assess the relative role played by the regulation of the Bcl-2 family genes, Bcl-2 and Bcl-X, in the IL-3 induced survival of Baf-3 cells, Baf-3 cells were cultured in the absence of IL-3 and Poly(A) + mRNA was prepared 0, 2, 4, 7 and 10 h later. Figure 1a shows that upon IL-3 removal the decrease of the Bcl-X 3 kb mRNA was rapid, with a signi®cant drop after 2 h and a minimum level reached after 4 h culture in absence of IL-3. Using an antibody directed against a peptide near the N-terminus, only the Bcl-XL isoform could be detected (Figure 1b) . Upon IL-3 starvation Bcl-XL protein levels were also found to decrease, although with slower kinetics, the ®rst signi®cant drop being seen after 7 h of culture in the absence of IL-3. Thus, the down-regulation of Bcl-XL expression precedes or coincides with the onset of apoptosis as only 10% of the cells were apoptotic after 7 h and an average of 10 to 12 h of culture in the absence of IL-3 was necessary to reach 50% apoptotic cells. In contrast, the levels of Bcl-2 7.5 kb mRNA remained constant for up to 10 h in the absence of IL-3 (Figure 1a ). Likewise the level of Bcl-2a protein was maintained constant during an 11 h IL-3 starvation time course (Figure 1b) . The death promoting gene Bax was not up regulated by IL-3 starvation (Figure 1a ), indicating that, in Baf-3 cells, down regulation of Bcl-2 or up regulation of Bax is not necessary for the apoptosis induced by growth factor starvation. Re-addition of IL-3 to Baf-3 cells starved of IL-3 for 10 h induced, within 1.5 h, up regulation of Bcl-X but not Bcl-2 or Bax mRNAs. The up regulation of Bcl-X mRNA induced by IL-3 was rapid. Figure 1c shows that an increase was found as soon as 30 min after IL-3 addition, reaching a plateau after 2 h. This up regulation was inhibited by actinomycin D but was not dependent on protein synthesis since IL-3 was able to induce similar levels of Bcl-X mRNA in the presence or absence of the protein synthesis inhibitor cycloheximide ( Figure 1d ). These results indicate that, in Baf-3 cells, the level of Bcl-XL but not Bcl-2a protein is tightly regulated by IL-3. + mRNA were analysed. The Northern blot was hybridised with the Bcl-X, Bcl-2, Bax and GAP-DH probes as described in Materials and methods. The percentage of apoptotic cells in the culture, at the time of RNA preparation is given. It corresponds to the sub-G1 fraction of cells which was measured by cell cycle analysis. (b) Protein lysates were prepared from Baf-3 cells starved of IL-3 for 0, 2, 4, 7 and 11 h. IL-3 was re-added to Baf-3 cells starved of IL-3 for 7 h and protein lysates were prepared 1, 2 and 4 h later. Detection of Bcl-X and Bcl-2 was done according to Materials and methods. The percentage of apoptotic cells in the culture, at the time of protein preparation is given. It corresponds to the sub-G1 fraction of cells which was measured by cell cycle analysis. (c) IL-3 was added to Baf-3 cells starved of IL-3 for 7 h. At the time of IL-3 readdition, the percentage of apoptotic cells measured by cell cycle analysis was 24%. Poly(A) + mRNA was prepared from cells after 0, 0.5, 1, 2 and 4 h incubation with IL-3. 3 mg of poly(A) + mRNA were analysed. The Northern blot was hybridised with the Bcl-X and GAP-DH probes. (d) Bcl-X mRNA induction by IL-3 is inhibited by actinomycin D and is independent of protein synthesis. IL-3 was added to Baf-3 cells which had been starved of IL-3 for 8 h. Total RNA was prepared 4 h after IL-3 re-addition. Actinomycin D 5 mg/ml or cycloheximide 10 mg/ml were added at the time of IL-3 re-addition. 10 mg of total RNA were analysed. The Northern blot was hybridised with the Bcl-X probe IL-3-deprivation-apoptosis is inhibited via two pathways Y Leverrier et al Short term inhibition of apoptosis by growth factors is mediated at the post-translational level and is not dependent on the induction of Bcl-X To establish whether the time course of apoptosis inhibition at the cellular level followed the Bcl-X mRNA induction kinetic, the inhibition of apoptosis by growth factors was studied at similar time points. The eects of IL-3 which induces survival and proliferation were compared to those of two other growth factors, IGF-1 and IL-4, which act mainly on the survival of Baf-3 cells. Baf-3 cells were cultured in Figure 2 Growth factor inhibition of apoptosis. Baf-3 cells were grown in the presence (&) or absence (&) of growth factors or growth factors were added back to cells after 8 (*) or 12 (~) h starvation. The growth factors used were IL-3 (a), IGF-1 (b) or IL-4 (c). The percentage of viable cells was measured by PI exclusion. All experiments were performed at least ®ve times, one representative experiment is shown. The short term inhibition of apoptosis is independent of protein or mRNA synthesis. Cells were treated with actinomycin D 5 mg/ml (d) or cycloheximide 10 mg/ml (e). Apoptosis of Baf-3 cells starved of IL-3 for 8 h was inhibited by addition of IL-3 (&), IL-3 and drug (!) or drug in the absence of IL-3 (!). The mean rescue value and standard deviation of three independent experiments is shown. In this representation the percentage of viable cells at the time of growth factor re-addition corresponds to 100 percent rescue. For points marked by (*) we have performed a statistical analysis (student test of the mean) on the data obtained in a minimum of three independent experiments and we found that the inhibition of apoptosis was signi®cant: a50.02, a being the probability that the values obtained in the absence of growth factor or the presence of growth factor+drugs are identical. Levels of Bcl-XL protein following IL-3 re-addition in the absence (&) or the presence (!) of cycloheximide 10 mg/ml (f).
Baf-3 cells were starved of IL-3 for 8 h before IL-3 re-addition. Proteins levels were measured 0, 3, 6 and 9 h after IL-3 re-addition. ECL autoradiographies were scanned with a molecular dynamics scanner, arbitrary units of Bcl-XL are given the absence of IL-3 and IL-3, IL-4 or IGF-1, were added 0, 8 and 12 h later. The percentage of live nonapoptotic cells was measured every 2 h by PI exclusion as described in the Materials and methods. Figure 2a and b show that IL-3 and IGF-1 addition completely inhibited any further decrease in cell viability and this was independent of the length of time cells were maintained in absence of IL-3. IL-4 was also able to inhibit apoptosis, but in contrast to IGF-1 and IL-3 which induced survival for 24 h or longer, only a shortterm inhibition of less than 4 h, could be achieved (Figure 2c ). Similar results were obtained at time points when less than 10% of Baf-3 cells were alive (data not shown). This indicates that asynchronous apoptosis induced by growth factors removal is reversible up to the point where the apoptosis effector phase is triggered. The inhibition of apoptosis by IL-3 and IGF-1 was initially independent of mRNA or protein synthesis (Figure 2d and e, and data not shown), as these growth factors could delay death by 2 h in the presence of actinomycin D and 8 to 10 h in the presence of cycloheximide. This delay is signi®cant and is dependant on the presence of IL-3. The small inhibition seen with cycloheximide alone was not found to be signi®cant. In addition the increase in Bcl-XL protein levels detected after a 6 h incubation with IL-3 was abrogated by the addition of cycloheximide (Figure 2f ). These results imply that one of the mechanisms of apoptosis inhibition mediated by growth factors acts at a post-translational level and is independent of Bcl-X re-induction. However, as these drugs block gene or protein expression, they become toxic for the cell and do not allow to measure the eects of long term inhibition of Bcl-X expression on the induction of cell death.
Long term inhibition of apoptosis by IL-3 and IGF-1 correlates with the induction of the Bcl-X transcription through a MAP-kinase dependent pathway
To determine if Bcl-X was necessary for the long-term survival of Baf-3, we compared the induction of Bcl-X by IL-3, IGF-1 or IL-4. Baf-3 cells were washed of IL-3 and growth factors were re-added either directly (Figure 3a) or after 7 h in culture in the absence of growth factor (Figure 3b ). IGF-1 and IL-3 induced expression of the Bcl-X gene, although the levels of Bcl-X mRNA were never as high with IGF-1 as with IL-3 (Figure 3b ). In contrast, IL-4 which only allows short term survival of Baf-3 was unable to induce Bcl-X. This was not due to lack of IL-4 signalling since cMyc induction could be detected under the same experimental conditions (Figure 3b ). These results indicate that long term survival of Baf-3 cells correlates with the induction of the Bcl-X gene and expression of the Bcl-XL isoform (Figure 1c and data not shown). MAP-kinase is activated by IL-3 and IGF-1 but not by IL-4 (Welham et al., 1992) and could be involved in the induction of the Bcl-X gene. To address the role of MAP-kinase in the regulation of the Bcl-X gene, we have studied the induction of Bcl-X by IL-3 in the Baf-3 sub-clone D16 which expresses a dominant negative form of MAP-kinase kinase. The phenotype of that clone has been described in detail elsewhere (Perkins et al., 1996) . Brie¯y, expression of the dominant negative MAP-kinase kinase results in a severely depressed activation of MAP-kinase in response to IL-3 and inhibition of apoptosis requires a higher concentration of IL-3. Baf-3 and D16 were grown in the absence of IL-3 for 7 h. Dierent concentrations of IL-3 were then added and RNA was prepared 4 h later. Level of Bcl-X mRNA induced by IL-3 were found to be much lower in D16 than Baf-3 parental cells (Figure 4 ). This decrease was not due to a lower level of IL-3 receptors on D16 cells as c-Myc induction by IL-3 was identical in D16 and parental Figure 4 Expression of the Bcl-X gene in Baf-3 cells expressing dominant negative MAP-kinase kinase. IL-3 0.005 u/ml, 0.5 u/ml and 5 u/ml was added to Baf-3 or D16 cells which have been starved of IL-3 for 8 h. At the time of IL-3 re-addition, the percentage of life cells measured by PI exclusion was 80% and 58% for Baf-3 and D16 respectively. Total RNA was prepared from cells after the 8 h Il-3 starvation period or after 4 h incubation with IL-3. 10 mg of total RNA were analysed. Northern blots were hybridised with the Bcl-X, c-Myc and the GAP-DH probes Baf-3. These results indicate that MAP-kinase is involved in the regulation of Bcl-X expression.
Discussion
In this study we have shown that growth factor induced inhibition of apoptosis takes place at the post translational level and correlates with the induction of the Bcl-X gene. This clari®es some of the apparent contradictions found in the literature. We show that IL-3, IGF-1 and IL-4 are able to induce short term inhibition of cell death in the absence of protein or RNA synthesis. This is in agreement with published data showing that in ®broblasts the inhibition of c-Myc induced apoptosis by growth factors is independent of protein synthesis (Harrington et al., 1994) . The proteins which are the targets of growth factor induced post translational modi®cations have not been identi®ed. Growth factors could act by positively regulating the activity of proteins capable of inhibiting apoptosis. These could be residual Bcl-2 like proteins or other unidenti®ed proteins. Alternatively, proteins responsible for the induction of apoptosis such as members of the ICE family of proteases could be directly inhibited by growth factors. Further experiments are necessary to address that issue. The long term inhibition of apoptosis which could be achieved with IL-3 and IGF-1, but not IL-4, correlated with the induction of Bcl-X gene expression. This increase is likely to play a role in the inhibition of apoptosis since constitutive expression of Bcl-X allows Baf-3 cells to survive for more than 24 h in the absence of growth factors (J Thomas et al., manuscript in preparation). At the protein level only the 28 kD Bcl-XL isoform which acts as an inhibitor of cell death was detected. Following IL-3 starvation the early decrease in the Bcl-X mRNA and protein levels preceeded the onset of apoptosis. In contrast no change in the Bcl-2 mRNA and protein levels could be detected at these early time points. This is in contradiction with some reports (Kinoshita et al., 1995a; Otani et al., 1993) , but not others (Canman et al., 1995; Cleveland et al., 1994) , where the regulation of Bcl-2 following IL-3 starvation has been studied. Our results, in Baf-3 cells, indicate that dierent pathways appear to regulate Bcl-2 and Bcl-X gene expression. Indeed there are now a number of systems where independent regulation of the Bcl-2 and Bcl-X genes has been suggested. For example, the induction by IL-2 of the Bcl-2 but not Bcl-X gene is inhibited by rapamycine (Miyazaki et al., 1995) while Bcl-X but not Bcl-2 is induced by the co-stimulatory molecules CD40 and CD28 (Boise et al., 1993; Choi et al., 1995; Miyazaki et al., 1995) .
Finally we show that MAP-kinase activation is required for the regulation of Bcl-X gene expression by IL-3. This is based on two separate lines of evidence. First, IL-3 and IGF-1 but not IL-4 have been shown to activate MAP-kinase and this correlated with Bcl-X induction in our system. Although the IL-4 signals are weak in Baf-3 cells, this growth factor can signi®cantly delay cell death and induce low levels of cMyc transcription. Second, in response to IL-3, Baf-3 cells expressing a dominant negative MAP-kinase kinase express the Bcl-X gene at signi®cantly lower levels than those found in wild-type cells. This eect was speci®c for Bcl-X as the levels of c-Myc induction was found to be identical in both types of cells. The inhibition of apoptosis in Baf-3 cells expressing a dominant negative MAP-kinase kinase requires higher IL-3 concentration compared to parental cells (Perkins et al., 1996) . That property could result in part from the lower level of Bcl-X which is induced in these cells by IL-3. These results complement with previously published data showing that activated Ras could induce the Bcl-X gene (Kinoshita et al., 1995b) and demonstrate that the MAP-kinase pathway is critical for the apoptosis inhibition. The Ras/MAP-kinase pathway has been shown to be involved in the regulation of cell survival in a number of systems (Fath et al., 1994; Kinoshita et al., 1995a; Swan et al., 1995) . For example MAP-kinase plays a key role in the inhibition of cell death which takes place following positive selection of T cells in the thymus . A decreased Bcl-X gene expression could be responsible for the increased apoptosis found in those systems.
Materials and methods

Cell culture and reagents
The bone marrow derived IL-3 dependent Baf-3 cells (Rodriguez-Tarduchy et al., 1990 ) and the D16 Baf-3 cells sub-clone containing the dominant negative MAP-kinase kinase (Perkins et al., 1996) were maintained in DMEM containing 6% foetal calf serum (Boehringer Mannheim), 2 mM L-glutamine (Gibco BRL) and 5% WEHI 3B cellconditioned medium as a source of IL-3. Cells were grown at a density of 5610 4 to 5610 5 per ml. To remove IL-3, cells were washed twice in DMEM/FCS 6%.
Propidium iodide (PI) exclusion was used to measure the percentage of viable cells. 5610 3 to 10 4 cells incubated with PI at a concentration of 5 mg/ml were analysed on a FacScan (Becton-dickinson) using a FSC/SSC gate to exclude debris. For each time point at least 5000 cells were analysed on FSC/ FL2 dot plot. This staining protocol allows the distinction between dead (FL-2 bright, FSC low), apoptotic (FL2 dull, FSC intermediate) and live cells (FL-2 negative, FSC high) (Schmid et al., 1994) . The percentage of viable cells corresponds to the percentage of FL-2 negative cells.
Murine IL-3, IL-4 and human IGF-1 (obtained from Genzyme) were used at concentration of 5 u/ml, 250 u/ml and 250 ng/ml respectively. These concentrations induced maximum Baf-3 viability as measured by PI exclusion in 20 h cultures.
Actinomycin D and cycloheximide were obtained from Sigma. Cycloheximide was used as a concentration of 10 mg/ ml which has previously been shown to inhibit more than 90% of protein synthesis in Baf-3 cells (Collins et al., 1992) . Actinomycin D was used at a dose of 5 mg/ml. At these concentrations, the viability of Baf-3 cells grown in the presence of IL-3 was not aected for 6 h in the case of actinomycin D and 12 h in the case of cycloheximide. Thereafter cell death induced by the drugs was observed.
Cell cycle analysis
5610
5 cells were pelleted, resuspended in 0.2 ml phosphate-buered saline (PBS), and ®xed by the addition of 1 ml of ice cold 70% ethanol in PBS. Fixed cells were pelleted, gently resuspended in PBS using a micropipette, and incubated for 30 min at 378C with 100 mg/ml RNase and 20 mg/ml PI. The¯uorescence of the stained cells was analysed using the Cellquest software on a FACScan.
Measurement of Bcl-X and Bcl-2 protein expression
Cells were washed in cold PBS and pellets were lysed for 5 min at 48C in lysis buer (10 mM KCl, 10 mM TrisHcl pH 8.1, 1 mM MgCl 2 , 0.1% NP40, 0.02 mM E64, 0.1 mM phenantroline, 0.1 mM DCI). Proteins obtained from 10 6 cells were separated in 12.5% polyacrylamide SDS ± PAGE gels. Gels were electroblotted onto nitro-cellulose membrane (BioRad) using a semi-dry transfer apparatus. Murine Bcl-XL was detected using polyclonal antibodies raised against the N-terminus of the murine Bcl-XL protein. Murine Bcl-2a was detected using an anti-Bcl-2 rabbit antiserum. Bound antibodies coupled to HRP were revealed by the DuPont NEN detection system.
RNA preparation and Northern analysis
Total cellular RNA was isolated by the RNA Now method according to the manufacturer's instruction (Biogentex). Poly(A) + mRNA was prepared using the polyAT tract mRNA isolation system (Promega). For Northern analysis, 10 mg of total RNA or 3 mg of poly(A) + mRNA were separated on a 1% agarose-formaldehyde gels and blotted onto hybon N membranes (Amersham). Filters were hybridised overnight at 428C with 32 P-labelled probes and washed by standard protocol.
DNA probes were labelled with [a 32 P]dCTP using a random priming kit (Amersham). The murine Bcl-XL probe is a 0.8 Kbp SacI/XhoI fragment and the murine Bax probe is a 0.6 Kbp KpnI/SacI fragment. Both contain the entire cDNA coding region. The murine Bcl-2 probe is a 0.6 Kbp BamHI/HindIII fragment containing the 5' exon and the murine GAP-DH probe is a 1 Kbp PstI fragment, the murine c-Myc probe is a HindIII/XbaI 2.8 Kbp cDNA fragment.
